Clinical Trial Update: Rituximab and GM-CSF in Treating Patients With Newly Diagnosed Follicular B-Cell Lymphoma [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating rituximab plus GM-CSF in newly diagnosed follicular lymphoma has completed enrollment with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Follicular Lymphoma

Drugs mentioned

• Rituximab (Rituxan) (rituximab)
• Sargramostim (Leukine) (sargramostim)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Lymphoma | Phase 2 | Status: COMPLETED | Results posted: 2017-12-05